These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 9333099

  • 1. Issues in pharmaceutical lotteries: the case of interferon beta-1b.
    Manocchia M, Lasagna L.
    Clin Pharmacol Ther; 1997 Sep; 62(3):241-7. PubMed ID: 9333099
    [No Abstract] [Full Text] [Related]

  • 2. Beta interferon, NICE, and rationing.
    Kernick D.
    Br J Gen Pract; 2002 Sep; 52(482):784-5. PubMed ID: 12236297
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Interferon beta-1b in multiple sclerosis--news regarding open questions].
    Nervenarzt; 1997 Aug; 68(8 Suppl Interferon):1-4. PubMed ID: 9380220
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. 10 years of interferon beta-1b (Beta feron therapy.
    Kappos L, Hartung HP.
    J Neurol; 2005 Sep; 252 Suppl 3():iii1-iii2. PubMed ID: 16170493
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [New trends, clinical questions and long-term experiences. Therapy of multiple sclerosis with interferon beta-1b].
    Nervenarzt; 1998 Nov; 69(11 Suppl Therapie D):1-8. PubMed ID: 9845885
    [No Abstract] [Full Text] [Related]

  • 13. [Clinical testing of the treatment effect of interferon-beta Ia and Ib in multiple sclerosis].
    de Haan RJ, Polman CH.
    Ned Tijdschr Geneeskd; 1996 Nov 02; 140(44):2168-71. PubMed ID: 8984352
    [No Abstract] [Full Text] [Related]

  • 14. [Beta interferon in multiple sclerosis: pharmacological differences].
    Allain H, Bentué-Ferrer D, Schück S, Ruffault A.
    Rev Neurol (Paris); 1999 Nov 02; 155 Suppl 2():S24-30. PubMed ID: 10367322
    [Abstract] [Full Text] [Related]

  • 15. Neutralizing antibodies (NABS) and interferon beta-1b therapy of multiple sclerosis.
    Horowski R, Stürzebecher CS, Kapp JF.
    Funct Neurol; 2001 Nov 02; 16(2):117-28. PubMed ID: 11495417
    [No Abstract] [Full Text] [Related]

  • 16. [The role of interferon beta in the treatment of multiple sclerosis].
    Seeldrayers P.
    Rev Med Brux; 1999 Sep 02; 20(4):A264-7. PubMed ID: 10523902
    [Abstract] [Full Text] [Related]

  • 17. Interferon-beta 1b: new hope for multiple sclerosis.
    Holdcroft C.
    Nurse Pract; 1994 Jan 02; 19(1):6. PubMed ID: 8139804
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Patients' views of interferon therapy in MS.
    Burgess M.
    Prof Nurse; 1998 Jun 02; 13(9):588-92. PubMed ID: 9782975
    [Abstract] [Full Text] [Related]

  • 20. [High doses of interferon in the treatment of multiple sclerosis].
    Muñoz D.
    Rev Neurol; 1998 Jun 02; 32(9):899. PubMed ID: 11424041
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.